Subtle%20Shapes%20Transparent_edited.png

ARCHBOW CONSULTING NEWS

News > Article

  • Team Archbow

Which pharmaceutical HUB design is right for you? Insource vs. Outsource vs. Hybrid.


Watch the archived webinar or read the whitepaper here

Which pharmaceutical HUB design is right for you? Insource vs. Outsource vs. Hybrid.


Providing patient support services via a HUB is a market access reality for virtually all specialty products in 2020.

For many, it may seem logical to replicate the service models of industry-leading HUBs. But the reality is that a manufacturer’s approach to HUB design should be just as unique as the product and its patient and prescriber populations.

That’s why HUB design should never be a one-size-fits-all approach. Today’s marketplace has so many options – sometimes, it may feel like TOO many – that a manufacturer must truly custom-design their HUB to not only meet their needs, but also the needs of multiple and varied stakeholders.

Determining if your HUB should be insourced, outsourced, or a hybrid of those two options is a big decision. And finding the right answer can determine the future success of your patient access program.

Primary HUB Models:

  • Outsourced: Manufacturer works with a third-party vendor to outsource all touch points with patients, HCPs, and payers

  • Insourced: Manufacturer builds capabilities and employs internal resources to fully support the patient journey with patients, HCPs, and payers

  • Hybrid: Manufacturer chooses to insource certain critical components while outsourcing other support functions to third-party vendors. The services that are insourced and outsourced vary from product to product and company to company.

When deciding which HUB model is best for your unique product, it’s important to understand the pros and cons of each model, which services will be most important to your brand, and to evaluate several key considerations that range from technology to human resources to data.

We’ve supported many manufacturers in this process over the years, and it’s become clear that aligning internally around these areas before designing your HUB can be a primary factor of success, even though it can seem daunting.

That’s where we can help. Archbow teamed up with FierceBiotech to host a webinar and write a whitepaper designed to assist manufacturers in choosing the right HUB model for their brand.

The archived webinar and whitepaper are available here.

There should never be a "one size fits all" approach to HUB design. We challenge you to think strategically about the services that will truly benefit your business. By identifying clear objectives, focusing on your own core competencies, and leveraging the experience of established vendors when needed, you can create a customized HUB program that your patients will truly consider best-in-class. When it's time for your team to get started, Archbow is here to help.




Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.


Pharmaceutical Consultants USA, Europe, Pharmaceutical Consulting Services USA, Europe, Biotech Consultants USA, Europe, Biotech Consulting Services USA, Europe, Pharmaceutical Market Access USA, Europe

SUBSCRIBE

Subscribe to receive news and updates from Archbow Consulting

Pharmaceutical and Biotech Consultancy Services in the USA and Europe

LET'S GET SOCIAL

CONTACT

USA Office

+1 (321) 355-2686

4700 Millenia Blvd., Suite 175, Orlando, FL 32839

Europe Office

+ 41 41 723 23 23

Dammstrasse 19 6300 Zug, Switzerland